---
document_datetime: 2023-09-21 20:27:16
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/insulin-aspart-sanofi-epar-all-authorised-presentations_en.pdf
document_name: insulin-aspart-sanofi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1740922
conversion_datetime: 2025-12-24 16:59:41.438289
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name       | Strength   | Pharmaceutical Form    | Route of Administration           | Immediate Packaging                            | Content (concentration)   | Pack size          |
|------------------|-----------------------|------------|------------------------|-----------------------------------|------------------------------------------------|---------------------------|--------------------|
| EU/1/20/1447/001 | Insulin aspart Sanofi | 100 U/ml   | Solution for injection | Subcutaneous use                  | cartridge (glass) in pre-filled pen (SoloStar) | 3 ml (3.5 mg/ml)          | 1 pre-filled pen   |
| EU/1/20/1447/002 | Insulin aspart Sanofi | 100 U/ml   | Solution for injection | Subcutaneous use                  | cartridge (glass) in pre-filled pen (SoloStar) | 3 ml (3.5 mg/ml)          | 5 pre-filled pens  |
| EU/1/20/1447/003 | Insulin aspart Sanofi | 100 U/ml   | Solution for injection | Subcutaneous use                  | cartridge (glass) in pre-filled pen (SoloStar) | 3 ml (3.5 mg/ml)          | 10 pre-filled pens |
| EU/1/20/1447/004 | Insulin aspart Sanofi | 100 U/ml   | Solution for injection | Subcutaneous use                  | cartridge (glass)                              | 3 ml (3.5 mg/ml)          | 5 cartridges       |
| EU/1/20/1447/005 | Insulin aspart Sanofi | 100 U/ml   | Solution for injection | Subcutaneous use                  | cartridge (glass)                              | 3 ml (3.5 mg/ml)          | 10 cartridges      |
| EU/1/20/1447/006 | Insulin aspart Sanofi | 100 U/ml   | Solution for injection | Intravenous use, Subcutaneous use | Vial (glass)                                   | 10 ml (3.5 mg/ml)         | 1 vial             |
| EU/1/20/1447/007 | Insulin aspart Sanofi | 100 U/ml   | Solution for injection | Intravenous use, Subcutaneous use | Vial (glass)                                   | 10 ml (3.5 mg/ml)         | 5 vials            |